Employers are seeing their pharmacy spend skyrocket due to GLP-1 prescriptions, and TPAs are under pressure to find cost-effective solutions. Embla helps employers significantly reduce medication costs by keeping members on the lowest effective dose. On average, members use 66 percent less GLP-1 medication while achieving the same or better weight loss results.

The key difference is our combination of low-dose protocols and ongoing behavioral coaching, which improves adherence, reduces side effects, and ensures members can taper off successfully when ready. This means fewer prescription claims, long-term weight management, and cost savings that directly benefit self-funded employers.

Most weight loss programs that include GLP-1s rely on a medication-first approach, which often escalates doses over time and drives up costs.

Embla takes a more strategic, cost-conscious approach by combining lower-dose medication protocols with personalized coaching to help members lose weight and sustain their results. This prevents the typical cycle of high-cost prescriptions, poor engagement, and weight regain.

Unlike traditional programs, our members don’t rely on long-term GLP-1 prescriptions—they get the behavioral support needed to maintain their weight loss, reducing pharmacy spend and long-term claims exposure for employers.

Embla is built for easy integration with minimal lift for TPAs.

The program is fully digital, doesn’t require changes to plan design, and can be positioned as a value-add to an employer’s existing benefits. There’s no claims processing or administrative burden — employers only pay for active participants, and we handle member engagement, coaching, and reporting.

We provide white-label materials and implementation support, making it easy for TPAs to introduce Embla as a cost-management solution for employers offering GLP-1 coverage or looking for an alternative approach to weight management.

Employers offering Embla see a reduction in GLP-1 spending without sacrificing outcomes.

Our data shows members lose an average of 16.7 percent of their body weight over 12 months while using significantly lower doses of medication compared to standard programs. That translates into real savings on pharmacy costs while ensuring members get better long-term results.

By helping employees taper off successfully and maintain their weight loss, Embla also helps reduce the risk of obesity-related claims down the line. For TPAs, this means offering a solution that not only saves money today but also leads to healthier, more engaged employees over time.

Embla is priced per active participant, so employers only pay for members who are engaged in the program.
This keeps costs predictable and ensures they’re only paying for real impact.

Our approach to optimizing medication use and supporting long-term weight maintenance also means indirect savings through lower pharmacy spend and fewer high-cost claims related to obesity. The pricing model is flexible and built to align with the needs of self-funded employers, making it an easy add-on for TPAs looking to offer a cost-effective weight management solution.